Paul L. Berns, Director at Jazz Pharmaceuticals plc (JAZZ), sold 801 shares at $183.36 ($144K) on 2015-08-10, disclosed to the SEC on 2015-08-11.
Seasonal sale ($144k) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $179.98 | 797 | $143K | 99.5% |
| 2 | $183.36 | 4 | $733 | 0.5% |
| Total | $180.00 avg | 801 | $144K | 100% |
| Filing → |
| NMRA | SELL | 2026-02-19 | $34K | — | Filing → |
| NMRA | SELL | 2025-02-20 | $23K | — | Filing → |
| MTSR | BUY | 2025-02-03 | $14.2M | — | Filing → |